VERAVera Therapeutics, Inc.

$35.29

What is the market doing?

What the tape says about VERA

Vera Therapeutics, Inc. is +62% over the past year while the S&P 500 is +20%: 42 points ahead of the market.

+62%

1-year return · S&P 500 +20%

vs 200-day average
−8.8%

vs 200-day average · below trend, but not far

RSI (14)
63

RSI (14) · neutral

Below its 52-week high
37%

Below its 52-week high

2024-08-15$18.86 – $55.67 · dashed line: 200-day average2026-09-08
Details
Last close2026-09-08
$35.29
1 monthS&P 500 −0.30%
+10%
1 yearS&P 500 +20%
+62%
5 yearsS&P 500 +85%
+111%
vs 50-day average$34.86
+1.3%
52-week high
$55.67
52-week low
$21.34
Annualised volatility
79%
Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
−$1.4M
Calendar-year price return
YearReturn
2026 (year to date)−30%
2025+20%
2024+175%
2023−21%
2022−28%
Average return by calendar month, 2021–2026
MonthYearsPositiveAverage
Jan51 of 5+5.8%
Feb52 of 5+1.6%
Mar52 of 5−4.8%
Apr50 of 5−10%
May51 of 5−4.9%
Jun63 of 6+16%
Jul64 of 6+8.5%
Aug64 of 6+2.0%
Sep64 of 6+8.0%
Oct51 of 5−7.1%
Nov54 of 5+29%
Dec53 of 5+7.8%

End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.